Tactive Advisors LLC Takes $407,000 Position in Lam Research Corporation $LRCX

Tactive Advisors LLC bought a new stake in shares of Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 4,180 shares of the semiconductor company’s stock, valued at approximately $407,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Lam Research by 1.1% during the second quarter. Vanguard Group Inc. now owns 130,609,265 shares of the semiconductor company’s stock worth $12,713,506,000 after purchasing an additional 1,457,163 shares in the last quarter. State Street Corp grew its holdings in Lam Research by 1.1% during the 2nd quarter. State Street Corp now owns 59,551,547 shares of the semiconductor company’s stock valued at $5,810,172,000 after purchasing an additional 629,666 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Lam Research by 14.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock worth $3,954,188,000 after buying an additional 5,102,589 shares during the period. Geode Capital Management LLC lifted its holdings in Lam Research by 3.5% in the 2nd quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock worth $3,280,484,000 after buying an additional 1,135,405 shares in the last quarter. Finally, Norges Bank purchased a new position in Lam Research in the 2nd quarter valued at about $1,894,585,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Lam Research

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the transaction, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 102,608 shares of company stock worth $14,916,496. Insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on LRCX. UBS Group reaffirmed a “buy” rating and set a $175.00 target price (up from $165.00) on shares of Lam Research in a research report on Tuesday, November 25th. Susquehanna raised their price objective on Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn lifted their price objective on Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Barclays set a $142.00 target price on Lam Research and gave the company an “equal weight” rating in a research note on Monday, October 20th. Finally, HSBC set a $127.00 price target on shares of Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $152.87.

Lam Research Stock Performance

LRCX stock opened at $160.52 on Monday. The stock’s 50 day simple moving average is $152.53 and its 200 day simple moving average is $120.50. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $169.69. The firm has a market cap of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.65 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s dividend payout ratio is 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.